Are Savencia's (EPA:SAVE) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. That said, the current statutory profit is not always a good guide to a company's underlying profitability. Today we'll focus on whether this year's statutory profits are a good guide to understanding Savencia (EPA:SAVE).
It's good to see that over the last twelve months Savencia made a profit of €73.0m on revenue of €4.99b. As you can see in the chart below, its profit has declined over the last three years, even though its revenue has increased.
View our latest analysis for Savencia
Importantly, statutory profits are not always the best tool for understanding a company's true earnings power, so it's well worth examining profits in a little more detail. This article will focus on the impact unusual items have had on Savencia's statutory earnings. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
How Do Unusual Items Influence Profit?
To properly understand Savencia's profit results, we need to consider the €44m expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Savencia to produce a higher profit next year, all else being equal.
Our Take On Savencia's Profit Performance
Because unusual items detracted from Savencia's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Savencia's earnings potential is at least as good as it seems, and maybe even better! And the EPS is up 46% over the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you'd like to know more about Savencia as a business, it's important to be aware of any risks it's facing. In terms of investment risks, we've identified 2 warning signs with Savencia, and understanding them should be part of your investment process.
This note has only looked at a single factor that sheds light on the nature of Savencia's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.
If you’re looking to trade Savencia, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
About ENXTPA:SAVE
Savencia
Produces, distributes, and markets dairy and cheese products in France, rest of Europe, and internationally.
Flawless balance sheet, undervalued and pays a dividend.